COMMUNIQUÉS West-GlobeNewswire

Voyager Therapeutics Announces Upcoming Data Presentations at the American Society of Gene and Cell Therapy 2019 Annual Meeting
15/04/2019
Five oral and seven poster presentations focus on Voyager’s preclinical programs, new capsid development efforts, and manufacturing capabilities CAMBRIDGE, Mass., April 15, 2019 (GLOBE NEWSWIRE) -- Voyager Therapeutics [...]
Amicus Therapeutics to Present Preclinical Pompe Disease Gene Therapy Data at the American Society of Gene & Cell Therapy (ASGCT) 22nd Annual Meeting
15/04/2019
CRANBURY, N.J., April 15, 2019 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced the company will present initial preclinical data from its investigational adeno-associated viral (AAV) gene therapy [...]
Sienna Announces April Dividend
15/04/2019
MARKHAM, Ontario, April 15, 2019 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“ Sienna ” or the “ Company ”) (TSX: SIA) today announced a dividend of $0.0765 per common share of the Company (each, a “Common Share”) [...]
Athersys to Host Investor Day in New York City
15/04/2019
Special Event to be Held Tuesday, May 14, 2019 CLEVELAND, Ohio, April 15, 2019 (GLOBE NEWSWIRE) -- Athersys, Inc. (Nasdaq: ATHX) announced today that the company will host an investor day on Tuesday, May 14, 2019. The [...]
Information regarding acquisition or disposal of a major holding
15/04/2019
Joint Stock Company “Grindeks” hereby informs that today, on 15 April 2019 it has received notifications of a disposal of major holding from its shareholders Kirovs Lipmans and Anna Lipmane and an acquisition of a major [...]
Konica Minolta KDR AU and KDR Primary DR Systems Receive Seismic Certification
15/04/2019
WAYNE. N.J., April 15, 2019 (GLOBE NEWSWIRE) -- Konica Minolta Healthcare Americas, Inc., announces the KDR™ Advanced U-Arm and KDR™ Primary Digital Radiography System have been certified in California to withstand [...]
Acasti Pharma Announces TRILOGY 1 Trial Has Achieved 100% Patient Randomization in Patients with Severe Hypertriglyceridemia
15/04/2019
More Than 40% of Patients Have Completed Their 6 Month Treatment Plan Top Line Results Remain On Track For Year-End Annual Performance Grants of Stock Options and Amendment of Stock Option Plan Announced LAVAL, Quebec, [...]
Precipio Announces 2018 Year-End Corporate Update Call for Shareholders
15/04/2019
Conference Call to Be Held On Monday, May 6th, 2019 at 5:00 PM ET NEW HAVEN, Conn., April 15, 2019 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. ( NASDAQ: PRPO ) will be hosting its 2018 year- [...]
Information regarding proposal preparation for the mandatory redemption of shares
15/04/2019
Joint Stock Company “Grindeks” hereby informs that today, on 15 April 2019 it has received the information from its shareholders Kirovs Lipmans, Anna Lipmane and Filips Lipmans that according to the agreement signed [...]
BioPorto Appoints New President of BioPorto Diagnostics, Inc.
15/04/2019
April 15, 2019 NEWS release BioPorto Appoints New President of BioPorto Diagnostics, Inc. Company Plans to Bring Novel Kidney Diagnostic to US Market Today, BioPorto A/S CPH: BIOPOR (“BioPorto”) announces the [...]
Genetic Technologies and The Translational Genomics Research Institute of Phoenix, Arizona Sign Memorandum of Understanding
15/04/2019
MELBOURNE, Australia, April 15, 2019 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG) (NASDAQ: GENE) (“Company”), a provider of world-leading genetic risk assessment test products, is pleased to announce that [...]
Alphatec Announces Sales Leadership Appointment And Successful Closing of Expanded Credit Facility With Squadron Capital
15/04/2019
Experienced Spine Executive David Sponsel Assumes Sales Leadership Role CARLSBAD, Calif., April 15, 2019 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (“ATEC” or the “Company”) (Nasdaq: ATEC), a provider of innovative [...]
Aptevo Therapeutics Reports IXINITY® and Pipeline Progress
15/04/2019
Reports 73% Increase in IXINITY Year-Over-Year Quarterly Net Revenue in Q1 2019 Anticipates Launching New IXINITY 3,000 IU Assay Mid-2019 Advances Dosing in Additional Cohorts in APVO436 and APVO210 Clinical Programs On [...]
Auris Medical Receives Positive Nasdaq Listing Determination
15/04/2019
Hamilton, Bermuda, April 15, 2019 (GLOBE NEWSWIRE) -- Hamilton, Bermuda, April 15, 2019 – Auris Medical Holding Ltd. (Nasdaq: EARS), a clinical-stage company dedicated to developing therapeutics that address important [...]
Adverum Biotechnologies Provides Clinical Program Update on ADVM-022 Gene Therapy for Wet AMD
15/04/2019
- Clinical Hold until Additional CMC Information is Reviewed by FDA - - Independent DMC Review of Safety Data from First Cohort of Six Patients with No SAEs or DLTs - - Adverum Plans to Present 24-Week Data from First [...]
Taconic Biosciences Launches TruBIOME™ to Create Animal Models with Custom Microbiome Profiles
15/04/2019
RENSSELAER, N.Y., April 15, 2019 (GLOBE NEWSWIRE) -- Taconic Biosciences, a global leader in providing genetically engineered rodent model solutions, announces the launch of TruBIOME TM , a first of its kind solution [...]
BioPorto Appoints New President of BioPorto Diagnostics, Inc.
15/04/2019
Company Plans to Bring Novel Kidney Diagnostic to US Market Hellerup, Denmark, April 15, 2019 (GLOBE NEWSWIRE) -- Today, BioPorto A/S CPH: BIOPOR (“BioPorto”) announces the appointment of Amy Winslow as President for [...]
Immuron sales surge by 66% in the Third Quarter of FY19
15/04/2019
Key Highlights: Immuron achieved 66% YoY growth in worldwide sales for the third quarter of FY19, ending March 31, 2019. In Australia Q3 sales of Travelan® surged ahead, growing 73% YoY. In the US Q3 sales of Travelan® [...]
Biofongicide Regalia® Maxx de Marrone Bio Innovations est approuvé dans la production du cannabis au Canada.
15/04/2019
Marrone Bio Innovations a sélectionné un nouveau distributeur canadien pour renforcer sa présence dans le marché croissant du cannabis. DAVIS, Californie, 15 avr. 2019 (GLOBE NEWSWIRE) -- Marrone Bio Innovations Inc. ( [...]

Pages